Sign inJoin waitlistJoin the waitlist

Naresh Bumma

Voting Member · Ohio State University Hospital

Credentials: · · · · · ·

History

Ohio State University Hospital
Present

Hematology and Medical Oncology
Cleveland Clinic Foundation
2015–2018
Internal Medicine
2012–2015
Doctor of Medicine
2007–2011

Research

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
New England Journal of Medicine · 2021 · 562 citations
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA
Blood · 2020 · 162 citations
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma
Journal of Clinical Oncology · 2024 · First of 32 authors · 152 citations

Abdullah Khan
26 papers
Ashley Rosko
25 papers
Don Benson
25 papers
Srinivas Devarakonda
25 papers
YE
Yvonne Efebera
20 papers
Francesca Cottini
17 papers
Elvira Umyarova
14 papers
HL
Hans Lee
10 papers
Jeffrey Zonder
10 papers
MC
Maria Chaudhry
10 papers
GK
Glenn Kroog
9 papers
NS
Nina Shah
9 papers

Clinical trials

Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma
Principal investigator · Recruiting · Phase 2
Naresh Bumma
2026–2027
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
Site PI · Recruiting · Phase 2
SCRI Development Innovations, LLC
2025–2033
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
Site PI · Recruiting
Tufts Medical Center
2024–2029